Table 3.
Age group (years) | Women |
Men |
Overall |
|||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
N | n | % | 95% CI | N | n | % | 95% CI | N | n | % | 95% CI | |
50–54 | 28 | 2 | 7.14 | 0.88–3.50 | 11 | 1 | 9.09 | 0.23–41.28 | 39 | 3 | 7.69 | 1.62–20.87 |
55–59 | 37 | 3 | 8.11 | 1.70–21.91 | 11 | 0 | 0.00 | 0.00–28.49 | 48 | 3 | 6.25 | 1.31–17.20 |
60–64 | 18 | 1 | 5.56 | 0.14–27.29 | 20 | 0 | 0.00 | 0.00–16.84 | 38 | 1 | 2.63 | 0.07–13.81 |
65–69 | 50 | 7 | 14.00 | 5.82–26.74 | 38 | 2 | 5.26 | 0.64–17.75 | 88 | 9 | 10.23 | 4.78–18.53 |
70–74 | 28 | 2 | 7.14 | 0.88–23.50 | 25 | 3 | 12.00 | 2.55–31.22 | 53 | 5 | 9.43 | 3.13–20.66 |
75–79 | 27 | 4 | 14.81 | 4.19–33.73 | 18 | 3 | 16.67 | 3.58–41.42 | 45 | 7 | 15.56 | 6.49–29.46 |
≥80 | 49 | 7 | 14.29 | 5.94–27.24 | 31 | 5 | 16.13 | 5.45–33.73 | 80 | 12 | 15.00 | 8.00–24.74 |
≥50 | 237 | 26 | 10.97 | 7.29–15.66 | 154 | 14 | 9.09 | 5.06–14.78 | 391 | 40 | 10.23 | 7.41–13.67 |
CI = Confidence interval; n = Number of herpes zoster patients of this gender in this age group with postherpetic neuralgia; N = Number of herpes zoster patients of this gender in this age group.